Order Article Reprints

Huang M-Y, Huang Y-J, Cheng T-L, Jhang W-Y, Ke C-C, Chen Y-T, Kuo S-H, Lin I-L, Huang Y-H, Chuang C-H. XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer. Cells. 2023; 12(11):1475. https://doi.org/10.3390/cells12111475

Huang, Ming-Yii, Yi-Jung Huang, Tian-Lu Cheng, Wun-Ya Jhang, Chien-Chih Ke, Yi-Ting Chen, Shih-Hsun Kuo, I-Ling Lin, Yu-Hsiang Huang, and Chih-Hung Chuang. 2023. "XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer" Cells 12, no. 11: 1475. https://doi.org/10.3390/cells12111475

Huang, M.-Y., Huang, Y.-J., Cheng, T.-L., Jhang, W.-Y., Ke, C.-C., Chen, Y.-T., Kuo, S.-H., Lin, I.-L., Huang, Y.-H., & Chuang, C.-H. (2023). XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer. Cells, 12(11), 1475. https://doi.org/10.3390/cells12111475